Burning Rock Biotech Ltd (BNR) stock is down -90.31% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BNR stock a score of 25 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 2. BNR's rank also includes a short-term technical score of 11. BNR has an Overall Score of 25. Find out what this means to you and get the rest of the rankings on BNR!